Luceda Photonics joins forces with Semitronix to accelerate photonics innovation Tuesday 12/08/2025 Luceda Photonics announced its acquisition by SMTX Technologies Singapore Pte. Ltd., part of Semitronix Group. This strategic partnership combines Luceda’s expertise in photonic integrated circuit (PIC) design software with Semitronix’s advanced semiconductor solutions. Precirix Receives FDA Green Light for Novel Cancer Therapy Monday 28/07/2025 VUB spin-off Precirix announced that the U.S. Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application for CAM-FAP-Ac-225. This significant achievement paves the way for Precirix to begin a Phase 1 clinical trial for patients battling FAP-positive tumors. ERIS Thursday 03/07/2025 The ERIS team proudly announces that the ERIS consortium has received an EU grant. Prof. dr. De Asmundis, programme director of the postgraduate Training in Cardiac Electrophysiology & Pacing, will coordinate this project for VUB. Swave Photonics raises €6M for holographic display technology Thursday 03/07/2025 Swave Photonics, a spin-off from imec and VUB, has raised an additional €6 million in Series A funding. This follow-on investment will accelerate the development of Swave's innovative holographic display technology for Spatial + AI Computing. Animab secures €10M for antibiotic-free animal health solution Tuesday 01/07/2025 Animab, a VUB-VIB-UGent spin-off, has secured €10 million in Series B funding to launch its innovative antibiotic-free solution for piglet health, tackling antimicrobial resistance. Annual Report 2024 of the Vice-rectorate Innovation & Industry Relations Wednesday 25/06/2025 Discover the real-world impact of VUB's innovative research in 2024 with our newly released Annual Report 2024. From new spin-offs to impactful industry collaborations, check out the full report for all the details. VUB spin-off Axiles Bionics secures €6M for bionic foot rollout Tuesday 24/06/2025 Axiles Bionics has successfully closed the first €6 million tranche of an €8 million Series A financing round. This significant investment will accelerate the global rollout of Lunaris, its cutting-edge biomimetic prosthetic foot, and advance the development of next-generation bionic devices. FC3 Thursday 19/06/2025 The ERIS team proudly announces that the FC3 consortium has received an EU grant. Prof. Hugo Thienpont, Director of Brussels Photonics at Vrije Universiteit Brussels, will coordinate this project for VUB. VUB, ULB and Sibelga Join Forces on Energy and Innovation Wednesday 11/06/2025 VUB, ULB and Sibelga signed a framework agreement to establish a long-term partnership in research, development, education, and training within the energy sector. CSI Cyprus seeks partners for Horizon Europe 2025 Proposals Friday 06/06/2025 The Center for Social Innovation (CSI Cyprus) is actively developing proposals for the upcoming Horizon Europe funding calls under Pillar II, specifically within Cluster 2 'Culture, Creativity, and Inclusive Society' and Cluster 3 'Civil Security for Society'. Spica Therapeutics and VUB/VIB join forces to advance cancer and immune disease therapies Wednesday 04/06/2025 Pioneering biotech company Spica, with headquarters in Belgium and roots and research in Denmark has announced a strategic collaboration with the Vrije Universiteit Brussel (VUB) and VIB. Axiles Bionics Showcased at Expo 2025 Osaka Monday 12/05/2025 VUB spin-off Axiles Bionics takes centre stage in the Belgian Pavilion, showcasing the Lunaris prosthetic foot, which mimics the natural motion of the human ankle. Pages « First ‹ Previous 1 2 3 (current) 4 5 6 7 8 9 … Next › Last »
